VectivBio Holding AG
VECT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $382 | $132 | $428 | $397 |
| - Cash | $221 | $103 | $40 | $20 |
| + Debt | $10 | $0 | $0 | $20 |
| Enterprise Value | $171 | $30 | $388 | $397 |
| Revenue | $27 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $27 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$80 | -$86 | -$58 | -$23 |
| % Margin | -292% | – | – | – |
| Net Income | -$94 | -$87 | -$60 | -$24 |
| % Margin | -342.8% | – | – | – |
| EPS Diluted | -2.12 | -3.23 | -2.4 | -1.01 |
| % Growth | 34.4% | -34.6% | -137.6% | – |
| Operating Cash Flow | -$56 | -$72 | -$38 | -$15 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$56 | -$72 | -$38 | -$15 |